DGCR5 Promotes Gallbladder Cancer by Sponging MiR-3619-5p via MEK/ERK1/2 and JNK/p38 MAPK Pathways: Erratum

Liu, Shilei; Chu, Bingfeng; Cai, Chen; Wu, Xiangsong; Yao, Wenyan; Wu, Ziyou; Yang, Ziyi; Li, Fengnan; Liu, Yingbin; Dong, Ping; Gong, Wei

doi:10.7150/jca.106439

Top

International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

open access Global reach, higher impact

PDF

J Cancer 2025; 16(2):496-497. doi:10.7150/jca.106439 This issue Cite

Erratum

DGCR5 Promotes Gallbladder Cancer by Sponging MiR-3619-5p via MEK/ERK1/2 and JNK/p38 MAPK Pathways: Erratum

Shilei Liu^1,2*, Bingfeng Chu^1,2*, Chen Cai^1,2, Xiangsong Wu^1,2, Wenyan Yao¹, Ziyou Wu¹, Ziyi Yang^1,2*, Fengnan Li^1,2*, Yingbin Liu^1,2*, Ping Dong^1,2, Wei Gong^1,2

1. Department of General Surgery, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, No. 1665 Kongjiang Road, Shanghai 200092, China
2. Shanghai Key Laboratory of Biliary Tract Disease Research, No. 1665 Kongjiang Road, Shanghai 200092, China
* These authors contributed equally to this work.

Citation:

Liu S, Chu B, Cai C, Wu X, Yao W, Wu Z, Yang Z, Li F, Liu Y, Dong P, Gong W. DGCR5 Promotes Gallbladder Cancer by Sponging MiR-3619-5p via MEK/ERK1/2 and JNK/p38 MAPK Pathways: Erratum. J Cancer 2025; 16(2):496-497. doi:10.7150/jca.106439. https://www.jcancer.org/v16p0496.htm

Other styles

Corrected-article in J Cancer, Volume 11, 5466

We recently found that there is an inadvertent mistake in our article entitled “DGCR5 Promotes Gallbladder Cancer by Sponging MiR-3619-5p via MEK/ERK1/2 and JNK/p38 MAPK Pathways”, due to our carelessness. In the article, the representative image of 'p-JNK' for the 'LV-NC' group in Figure 6G was inadvertently misplaced during the image editing process. We would like to correct this with the appropriate image in Figure 6G below. The correction does not affect the original results and conclusions. We are sorry for this mistake and apologize for any inconvenience caused.

Figure 6

DGCR5 knockdown significantly suppressed tumor growth in vivo. G. IHC staining assay was conducted to detect the expression of the key markers in tumor tissue, the relative expression is showed in the bar charts. * P < 0.05, ** P < 0.01, *** P < 0.001.

Author contact

Corresponding authors: Ping Dong, (e-Mail: dongpingcom.cn); Wei Gong, (e-Mail: 13651819806com)

Published 2025-1-1

Citation styles

APA

Liu, S., Chu, B., Cai, C., Wu, X., Yao, W., Wu, Z., Yang, Z., Li, F., Liu, Y., Dong, P., Gong, W. (2025). DGCR5 Promotes Gallbladder Cancer by Sponging MiR-3619-5p via MEK/ERK1/2 and JNK/p38 MAPK Pathways: Erratum. Journal of Cancer, 16(2), 496-497. https://doi.org/10.7150/jca.106439.

ACS

Liu, S.; Chu, B.; Cai, C.; Wu, X.; Yao, W.; Wu, Z.; Yang, Z.; Li, F.; Liu, Y.; Dong, P.; Gong, W. DGCR5 Promotes Gallbladder Cancer by Sponging MiR-3619-5p via MEK/ERK1/2 and JNK/p38 MAPK Pathways: Erratum. J. Cancer 2025, 16 (2), 496-497. DOI: 10.7150/jca.106439.

NLM

CSE

Liu S, Chu B, Cai C, Wu X, Yao W, Wu Z, Yang Z, Li F, Liu Y, Dong P, Gong W. 2025. DGCR5 Promotes Gallbladder Cancer by Sponging MiR-3619-5p via MEK/ERK1/2 and JNK/p38 MAPK Pathways: Erratum. J Cancer. 16(2):496-497.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.